Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|November 5, 2004
Dose sparing with intradermal injection of influenza vaccineRichard T Kenney, Sarah A Frech, Larry R Muenz, et al.
Expert Review of Vaccines|August 6, 2003
Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skinGregory M Glenn, Richard T Kenney, Larry R Ellingsworth, et al.
Vaccine|February 23, 2007
Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge studyRobin McKenzie, A Louis Bourgeois, Sarah A Frech, et al.
Vaccine|May 6, 2008
Controlled, single-step, stratum corneum disruption as a pretreatment for immunization via a patchDavid M Frerichs, Larry R Ellingsworth, Sarah A Frech, et al.
Expert Review of Vaccines|October 13, 2007
Transcutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patchGregory M Glenn, David C Flyer, Larry R Ellingsworth, et al.
Infection and Immunity|January 31, 2007
Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneumGregory M Glenn, Christina P Villar, David C Flyer, et al.
Vaccine|December 18, 2004
Improved immune responses to influenza vaccination in the elderly using an immunostimulant patchSarah A Frech, Richard T Kenney, Christian A Spyr, et al.
Vaccine|December 17, 2009
Safety and immunogenicity of an influenza vaccine A/H5N1 (A/Vietnam/1194/2004) when coadministered with a heat-labile enterotoxin (LT) adjuvant patchGregory M Glenn, D Nigel Thomas, Kimber L Poffenberger, et al.
The Journal of Infectious Diseases|July 24, 2004
Induction of protective immunity against lethal anthrax challenge with a patchRichard T Kenney, Jianmei Yu, Mimi Guebre-Xabier, et al.
Lancet (London, England)|June 17, 2008
Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trialSarah A Frech, Herbert L Dupont, A Louis Bourgeois, et al.
Pageof 1